363 related articles for article (PubMed ID: 31426855)
21. From discovery to the clinic: the novel DNA methylation biomarker (m)SEPT9 for the detection of colorectal cancer in blood.
Payne SR
Epigenomics; 2010 Aug; 2(4):575-85. PubMed ID: 22121975
[TBL] [Abstract][Full Text] [Related]
22. Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study.
Bergheim J; Semaan A; Gevensleben H; Groening S; Knoblich A; Dietrich J; Weber J; Kalff JC; Bootz F; Kristiansen G; Dietrich D
Br J Cancer; 2018 May; 118(9):1217-1228. PubMed ID: 29610456
[TBL] [Abstract][Full Text] [Related]
23. SOX14 hypermethylation as a tumour biomarker in cervical cancer.
Zhao J; Cao H; Zhang W; Fan Y; Shi S; Wang R
BMC Cancer; 2021 Jun; 21(1):675. PubMed ID: 34098886
[TBL] [Abstract][Full Text] [Related]
24. Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening.
Zhao G; Li H; Yang Z; Wang Z; Xu M; Xiong S; Li S; Wu X; Liu X; Wang Z; Zhu Y; Ma Y; Fei S; Zheng M
Cancer Med; 2019 Sep; 8(12):5619-5628. PubMed ID: 31407497
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-138 is a potential biomarker and tumor suppressor in human cervical carcinoma by reversely correlated with TCF3 gene.
Li H; Sheng Y; Zhang Y; Gao N; Deng X; Sheng X
Gynecol Oncol; 2017 Jun; 145(3):569-576. PubMed ID: 28385388
[TBL] [Abstract][Full Text] [Related]
26. High methylation of the SEPT9 gene in Chinese colorectal cancer patients.
Su XL; Wang YF; Li SJ; Zhang F; Cui HW
Genet Mol Res; 2014 Jan; 13(2):2513-20. PubMed ID: 24535900
[TBL] [Abstract][Full Text] [Related]
27. CADM1, MAL, and miR124 Promoter Methylation as Biomarkers of Transforming Cervical Intrapithelial Lesions.
Del Pino M; Sierra A; Marimon L; Martí Delgado C; Rodriguez-Trujillo A; Barnadas E; Saco A; Torné A; Ordi J
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067838
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions.
Dietrich D; Jung M; Puetzer S; Leisse A; Holmes EE; Meller S; Uhl B; Schatz P; Ivascu C; Kristiansen G
PLoS One; 2013; 8(12):e84225. PubMed ID: 24386354
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of HMGB1 by miR-34a is sufficient to suppress proliferation, migration and invasion of human cervical and colorectal cancer cells.
Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
Tumour Biol; 2016 Oct; 37(10):13155-13166. PubMed ID: 27456356
[TBL] [Abstract][Full Text] [Related]
30. The role of
Sun J; Fei F; Zhang M; Li Y; Zhang X; Zhu S; Zhang S
BMC Cancer; 2019 May; 19(1):450. PubMed ID: 31088406
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-492 overexpression involves in cell proliferation, migration, and radiotherapy response of cervical squamous cell carcinomas.
Liu M; An J; Huang M; Wang L; Tu B; Song Y; Ma K; Wang Y; Wang S; Zhu H; Xu N; Wu L
Mol Carcinog; 2018 Jan; 57(1):32-43. PubMed ID: 28802022
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic silencing of Rab39a promotes epithelial to mesenchymal transition of cervical cancer through AKT signaling.
Zou C; Fan J; He M; Xu Y; Wang K; Cai Y; Li M
Exp Cell Res; 2019 May; 378(2):139-148. PubMed ID: 30826396
[TBL] [Abstract][Full Text] [Related]
33. MiR-1284 enhances sensitivity of cervical cancer cells to cisplatin via downregulating HMGB1.
Chen J; Li G
Biomed Pharmacother; 2018 Nov; 107():997-1003. PubMed ID: 30257412
[TBL] [Abstract][Full Text] [Related]
34. Association between dense PAX1 promoter methylation and HPV16 infection in cervical squamous epithelial neoplasms of Xin Jiang Uyghur and Han women.
Zhang L; Hu D; Wang S; Zhang Y; Pang L; Tao L; Jia W
Gene; 2020 Jan; 723():144142. PubMed ID: 31589957
[TBL] [Abstract][Full Text] [Related]
35. [Expression of Micro-RNA 218 in Cervical Cancer and Its Effect on Proliferation, Apoptosis and Invasion of HeLa Cells].
Shi YR; Liu J; He W; Yang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 47(5):697-702. PubMed ID: 28598082
[TBL] [Abstract][Full Text] [Related]
36. The role of vimentin as a methylation biomarker for early diagnosis of cervical cancer.
Jung S; Yi L; Kim J; Jeong D; Oh T; Kim CH; Kim CJ; Shin J; An S; Lee MS
Mol Cells; 2011 May; 31(5):405-11. PubMed ID: 21491170
[TBL] [Abstract][Full Text] [Related]
37. MiR-1266 promotes cell proliferation, migration and invasion in cervical cancer by targeting DAB2IP.
Wang J; Liu Y; Wang X; Li J; Wei J; Wang Y; Song W; Zhang Z
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3623-3630. PubMed ID: 30261286
[TBL] [Abstract][Full Text] [Related]
38. The role of the hypoxia-Nrp-1 axis in the activation of M2-like tumor-associated macrophages in the tumor microenvironment of cervical cancer.
Chen XJ; Wu S; Yan RM; Fan LS; Yu L; Zhang YM; Wei WF; Zhou CF; Wu XG; Zhong M; Yu YH; Liang L; Wang W
Mol Carcinog; 2019 Mar; 58(3):388-397. PubMed ID: 30362630
[TBL] [Abstract][Full Text] [Related]
39. HPV16 E7-induced upregulation of KDM2A promotes cervical cancer progression by regulating miR-132-radixin pathway.
Ou R; Zhu L; Zhao L; Li W; Tao F; Lu Y; He Q; Li J; Ren Y; Xu Y
J Cell Physiol; 2019 Mar; 234(3):2659-2671. PubMed ID: 30132864
[TBL] [Abstract][Full Text] [Related]
40. Performance of a Novel Blood-Based Early Colorectal Cancer Screening Assay in Remaining Serum after the Blood Biochemical Test.
Chen Y; Wang Z; Zhao G; Sun C; Ma Y; Zhang L; Zheng M; Li H
Dis Markers; 2019; 2019():5232780. PubMed ID: 31089394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
